Author Archives: Jan Paschal

Accelevation Holdings (ACCV Proposed) outlined the terms today for its $660 million IPO: 30 million shares at a price range of $20.00 to $24.00 to raise $660 million, if priced at the $22.00 mid-point of its range. This is a NASDAQ listing. Of the 30 million shares in the IPO, Accelevation is offering 8.64 million […]

Oura (OURA Proposed), known for its health-focused smart rings, unveiled its $2.1 billion IPO early today and launched the deal to price next week. San Francisco-based Oura’s IPO consists of 50 million shares at a  price range of $40.00 to $44.00 to raise $2.1 billion, if priced at the $42.00 mid-point of its range. The […]

ADARx Pharmaceuticals (ADRX Proposed) disclosed the terms for its $350 million IPO early today: 21.88 million shares at a price range of $15.00 to $17.00 to raise $350 million, if priced at the $16.00 mid-point of its range, according to its S-1/A filing dated Sept. 21, 2026. The IPO is expected to price this week. […]

Bamboo Insurance Services (BMB Proposed) – a $665 million deal – is the only large IPO on tap for the last full week in September. The IPO Calendar shows just two deals with firm pricing dates this week. The light IPO Calendar  follows last week’s volatility in the broad U.S. stock market and the Fed’s […]

Anthropic is on track to launch its highly anticipated IPO – most likely in November, according to a story posted online by The New York Times late this afternoon (Friday, Sept. 18, 2026).  That expected timing matches projections by some Wall Street pros, who say that they think Anthropic should wait to launch its IPO until […]

Electra Therapeutics (ETRA) upsized its IPO at pricing to 23.33 million shares – up from 21.67 million shares in the prospectus – and priced the IPO at $15.00 – the mid-point of its $14.00-to-$16.00 range – to raise $349.95 million on Thursday night, Sept. 17, 2026. Electra Therapeutics’ IPO rode the wave of strong demand from biotech and […]

Orion180 Insurance Group (OIG) priced its IPO at $12.00 – $3.00 below the bottom of its $15.00-to-$17.00 range in the prospectus – and sold 20 million shares – the number in the prospectus – to raise $240 million on Thursday night, Sept. 17, 2026. (Editor’s Note: This column, published Thursday night, Sept. 17, 2026, was […]

West Palm Beach, Florida-based Haymaker Acquisition V (HYACU) priced its SPAC IPO in sync with the terms in its prospectus – 25 million units at $10.00 each – and raised $250 million on Wednesday night, Sept. 16, 2026. Haymaker Acquisition V became the first IPO to get priced after the Federal Reserve raised its benchmark […]

American Savings Bank (ASBH) of Hawaii upsized its IPO to about 8.06 million shares – up from about 7.5 million in the prospectus – and priced the deal at $16.00 – the mid-point of its $15.00 to $17.00 price range – to raise $128.92 million on Tuesday night, Sept. 15, 2026, the bank said in a statement. […]

Electra Therapeutics (ETRA proposed), a late-stage biotech focused on cancer and autoimmune disorders, set the terms early today for its IPO: 21.67 million shares at a price range of $14.00 to $16.00 to raise $325.05 million, if priced at the $15.00 mid-point of its range, according to its S-1/A filing dated Sept. 14, 2026. The […]